Glenmark Life Sciences (GLS.NSE) Q1 2024 Earnings

Apr 25Confirmed
Q1 2024
8
9.55
11.1
12.64

Details

Expected EPS
12.644374548795
Actual EPS
7.9964424024
Surprise EPS
-4.65
Surprise Percent
-36.76%

Description

⁨Glenmark Life Sciences⁩ (⁦GLS.NSE⁩) has reported earnings of ⁦7.9964424024⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts